|
| Accession | ID | Description | Gene | PANTHER
family/subfamily | PANTHER protein class | PANTHER GO-slim
molecular function | PANTHER GO-slim biological process | PANTHER GO-slim
cellular component | Pathway |
|
| P61158 | ARP3_
HUMAN | Actin-related
protein 3 | ACTR3 | Actin-related protein 3
(PTHR11937:SF175) | Actin and actin-related
protein(PC00085) | Structural constituent
of cytoskeleton
(GO:0005198) | Cytokinesis(GO:0009987);
mitosis(GO:0000910);
cellular component
morphogenesis(GO:0007049);
intracellular protein
transport(GO:0007067);
exocytosis(GO:0032502);
endocytosis(GO:0009653);
cellular component
organization(GO:0032989) | Actin cytoskeleton(GO:0043226);
intracellular(GO:0005856) | |
|
| P02765 | FETUA_
HUMAN | Alpha-2-HS-glycoprotein | AHSG | Alpha-2-HS-glycoprotein
(PTHR13814:SF6) | Extracellular matrix
glycoprotein(PC00102);
cysteine protease
inhibitor(PC00100) | Cysteine-type peptidase
activity(GO:0003824);
protein binding (GO:0016787); cysteine-type
endopeptidase inhibitor
activity (GO:0008233) | Immune system
process(GO:0002376);
proteolysis(GO:0008152);
mesoderm
development(GO:0044238);
skeletal system
development(GO:0019538);
regulation of catalytic
activity (GO:0006508) | Extracellular region
(GO:0005576);
extracellular matrix
(GO:0031012) | |
|
| P38606 | VATA_
HUMAN | V-type proton
ATPase catalytic
subunit A | ATP6V1A | V-type proton atpase
catalytic subunit A
(PTHR15184:SF7) | ATP synthase(PC00227); anion channel (PC00068); ligand-gated ion channel (PC00002); ligand-gated ion channel (PC00133); DNA-binding protein (PC00049); hydrolase
(PC00141) | Hydrolase activity
(GO:0003824); receptor
activity (GO:0016787);
anion channel activity (GO:0004872);
ligand-gated ion channel
activity (GO:0005215);
cation transmembrane
transporter activity
(GO:0022857);
proton-transporting
ATP synthase activity,
rotational mechanism (GO:0005216);
single-stranded DNA
binding (GO:0005253) | Respiratory electron
transport chain
(GO:0008152);
purine nucleobase
metabolic process
(GO:0006091); cation
transport (GO:0022904) | Proton-transporting
ATP synthase complex
(GO:0032991); intracellular
(GO:0043234) | |
|
| P62158 | CALM_
HUMAN | Calmodulin | CALM1 | Calmodulin
(PTHR23050:SF216) | Calmodulin (PC00060) | Calcium ion binding (GO:0005488);
calmodulin binding
(GO:0005509) | Cellular component
movement (GO:0009987);
cell cycle (GO:0006928);
cell communication
(GO:0007049) | | CCKR signaling
map→CaM; B cell
activation→calmodulin;
heterotrimeric
G-protein signaling
pathway-rod
outer segment
phototransduction→
calmodulin; T
cell activation→
calmodulin |
| P48643 | TCPE_
HUMAN | T-complex
protein 1
subunit epsilon | CCT5 | T-complex protein
1 subunit epsilon (PTHR11353:SF94) | Chaperonin (PC00072) | | Protein folding
(GO:0008152);
protein complex
assembly (GO:0044238);
protein complex
biogenesis (GO:0019538) | | |
|
| Q9UKY7 | CDV3_
HUMAN | Protein CDV3
homolog | CDV3 | Protein CDV3 homolog (PTHR16284:SF13) | | | | | |
|
| P09497 | CLCB_
HUMAN | Clathrin light
chain B | CLTB | Clathrin light
chain B (PTHR10639:SF2) | Vesicle coat
protein (PC00150) | | Intracellular protein
transport (GO:0051179);
receptor-mediated
endocytosis (GO:0006810) | Vesicle coat (GO:0032991);
cytoplasm (GO:0043234) | Heterotrimeric
G-protein signaling
pathway-Gq alpha and
Go alpha-mediated
pathway→clathrin;
heterotrimeric
G-protein signaling
pathway-Gi alpha and
Gs alpha-mediated
pathway→clathrin;
Huntington
disease→clathrin |
|
| P20674 | COX5A_
HUMAN | Cytochrome C
oxidase subunit
5A, mitochondrial | COX5A | Cytochrome C
oxidase subunit 5A,
mitochondrial
(PTHR14200:SF11) | Oxidase(PC00176) | Oxidoreductase
activity (GO:0003824) | Oxidative phosphorylation
(GO:0008152); respiratory
electron transport
chain (GO:0006091) | | |
|
| P07108 | ACBP_
HUMAN | Acyl-CoA-binding
protein | DBI | Acyl-CoA-binding
protein
(PTHR23310:SF54) | Transfer/carrier
protein (PC00219);
enzyme modulator
(PC00095) | Catalytic activity
(GO:0003824);
protein binding (GO:0005488);
enzyme inhibitor
activity (GO:0005515) | Lipid metabolic
process (GO:0008152);
lipid transport
(GO:0044238); regulation
of catalytic activity
(GO:0006629) | | |
|
| Q15075 | EEA1_
HUMAN | Early endosome
antigen 1 | EEA1 | Early endosome
antigen 1
(PTHR23164:SF6) | | | | | |
|
| Q92538 | GBF1_
HUMAN | Golgi-specific
brefeldin
A-resistance
guanine nucleotide
exchange factor 1 | GBF1 | Golgi-specific brefeldin
A-resistance guanine
nucleotide exchange
factor 1
(PTHR10663:SF138) | Signaling molecule
(PC00207);
guanyl-nucleotide
exchange factor
(PC00095); cytoskeletal
protein (PC00022) | GTPase activity
(GO:0003824);
pyrophosphatase
activity (GO:0016787);
nucleotide binding
(GO:0003924); small
GTPase regulator
activity (GO:0016462);
guanyl-nucleotide
exchange factor
activity (GO:0005488) | Phosphate-containing
compound metabolic
process (GO:0008152);
nitrogen compound
metabolic process
(GO:0006796); catabolic
process (GO:0006807);
nucleobase-containing
compound metabolic
process (GO:0009056);
cellular process
(GO:0044238); transport
(GO:0006139); regulation
of biological process
(GO:0009987); regulation
of catalytic activity
(GO:0051179) | Organelle (GO:0043226);
intracellular(GO:0044464) | |
|
| P78417 | GSTO1_
HUMAN | Glutathione
S-transferase
omega-1 | GSTO1 | Glutathione
S-transferase omega-1 (PTHR11260:SF323) | Transferase (PC00220);
signaling molecule
(PC00207); reductase
(PC00176); translation
elongation factor
(PC00198); epimerase/
racemase (PC00171);
cytoskeletal protein
(PC00031) | Oxidoreductase
activity (GO:0003824);
transferase activity
(GO:0016491);
racemase and
epimerase activity
(GO:0016740);
structural constituent
of cytoskeleton
(GO:0016853); translation
elongation factor
activity (GO:0016854);
translation elongation
factor activity
(GO:0005198); receptor
binding (GO:0005200);
translation elongation
factor activity
(GO:0005488) | Immune system
process (GO:0002376);
translation (GO:0008152);
cell communication
(GO:0044238); response
to toxic substance
(GO:0019538); regulation
of translation (GO:0006412) | Cytoskeleton (GO:0043226);
intracellular (GO:0005856) | |
|
| P09211 | GSTP1_
HUMAN | Glutathione
S-transferase P | GSTP1 | Glutathione S-transferase P
(PTHR11571:SF141) | | | | | |
|
| P51858 | HDGF_
HUMAN | Hepatoma-derived
growth factor | HDGF | Hepatoma-derived
growth factor (PTHR12550:SF41) | Transcription
cofactor (PC00218);
growth factor (PC00217) | Transcription
cofactor activity
(GO:0000988);
sequence-specific
DNA-binding
transcription factor
activity (GO:0000989); sequence-specific
DNA-binding
transcription factor
activity (GO:0003712);
growth factor
activity (GO:0001071) | Immune system
process (GO:0002376);
transcription from
RNA polymerase II
promoter (GO:0008152);
cell-cell signaling (GO:0044238); regulation
of transcription from
RNA polymerase II
promoter (GO:0006139) | | |
|
| O60814 | H2B1K_
HUMAN | Histone H2B
type 1-K | HIST1H2BK | Histone H2B type 1-K
(PTHR23428:SF23) | Histone (PC00171) | Nucleic acid
binding
(GO:0005488) | Nitrogen compound
metabolic process
(GO:0008152);
DNA metabolic
process (GO:0006807);
cellular process
(GO:0044238); chromatin
organization (GO:0006139);
chromatin assembly
(GO:0006259); cellular
component biogenesis
(GO:0009987) | Protein DNA complex
(GO:0032991); nucleus
(GO:0032993);
nuclear chromosome
(GO:0043226); intracellular
(GO:0005634) | |
|
| P17096 | HMGA1_
HUMAN | High mobility
group protein
HMG-I/HMG-Y | HMGA1 | High mobility group
protein HMG-I/HMG-Y
(PTHR23341:SF1) | DNA-binding
protein (PC00171) | Nucleic acid-binding
transcription factor
activity (GO:0001071);
lyase activity
(GO:0003824); DNA
binding (GO:0016829) | Nitrogen compound
metabolic process
(GO:0008152);
biosynthetic process
(GO:0006807); DNA repair
(GO:0009058); transcription,
DNA-dependent (GO:0044238); cellular
process (GO:0006139);
response to stress
(GO:0006259); regulation
of nucleobase-containing
compound metabolic
process (GO:0006281) | Organelle (GO:0043226);
intracellular (GO:0044464) | |
|
| P52926 | HMGA2_
HUMAN | High mobility
group protein
HMGI-C | HMGA2 | High mobility group
protein HMGI-C
(PTHR23341:SF4) | DNA-binding
protein (PC00171) | Nucleic acid-binding
transcription factor
activity (GO:0001071);
lyase activity (GO:0003824);
DNA binding (GO:0016829) | Nitrogen compound
metabolic process
(GO:0008152); biosynthetic
process (GO:0006807);
DNA repair (GO:0009058);
transcription,
DNA-dependent (GO:0044238); cellular
process (GO:0006139);
response to stress
(GO:0006259); regulation
of nucleobase-containing
compound metabolic
process 2(GO:0006281) | Organelle (GO:0043226);
intracellular (GO:0044464) | |
|
| P09429 | HMGB1_
HUMAN | High mobility
group
protein B1 | HMGB1 | High mobility group
protein B1-related
(PTHR13711:SF164) | HMG box transcription
factor (PC00218);
signaling molecule
(PC00024); chromatin/
chromatin-binding
protein (PC00207) | | | | p53 pathway→high
mobility group
protein 1 |
|
| P05114 | HMGN1_
HUMAN | Nonhistone
chromosomal
protein HMG-14 | HMGN1 | Nonhistone
chromosomal protein HMG-14 (PTHR23087:SF12) | Chromatin/
chromatin-
binding protein (PC00171) | Nucleic acid
binding (GO:0005488);
chromatin binding
(GO:0003676) | DNA replication
(GO:0008152); transcription
from RNA polymerase
II promoter (GO:0044238);
cell cycle (GO:0006139) | | |
|
| P05204 | HMGN2_
HUMAN | Nonhistone
chromosomal
protein HMG-17 | HMGN2 | Nonhistone
chromosomal
protein HMG-17 (PTHR23087:SF13) | Chromatin/chromatin-
binding protein (PC00171) | Nucleic acid binding (GO:0005488);
chromatin binding
(GO:0003676) | DNA replication
(GO:0008152);
transcription from RNA
polymerase II promoter
(GO:0044238); cell
cycle (GO:0006139) | | |
|
| P61604 | CH10_
HUMAN | 10 kDa heat
shock protein,
mitochondrial | HSPE1 | 10 kDa heat shock
protein, mitochondrial
(PTHR10772:SF16) | Chaperonin (PC00072) | | Protein metabolic
process (GO:0008152) | | |
|
| P50213 | IDH3A_
HUMAN | Isocitrate
dehydrogenase
[NAD]
subunit alpha,
mitochondrial | IDH3A | Isocitrate dehydrogenase
[NAD] subunit alpha,
mitochondrial
(PTHR11835:SF34) | Dehydrogenase
(PC00176) | Oxidoreductase
activity (GO:0003824) | Generation of precursor
metabolites and
energy (GO:0008152);
carbohydrate metabolic
process (GO:0006091);
tricarboxylic acid
cycle (GO:0044238) | | Ascorbate
degradation→
L-xylulose-5-phosphate-
3-epimerase; leucine
biosynthesis→
3-isopropylmalate
dehydrogenase |
|
| P01861 | IGHG4_
HUMAN | Ig gamma-4
chain C region | IGHG4 | IG gamma-1 chain c
region-related
(PTHR23266:SF83) | | | | | |
|
| Q9GZP8 | IMUP_
HUMAN | Immortalization
upregulated
protein | IMUP | Immortalization
upregulated protein
(PTHR21830:SF0) | | | | | |
|
| P04732 | MT1E_
HUMAN | Metallothionein-1E | MT1E | Metallothionein-1E (PTHR23299:SF2) | | | | | |
|
| P13640 | MT1G_
HUMAN,
MT1X_
HUMAN,
MT2_
HUMAN | Metallothionein-1G,
metallothionein-1X, metallothionein-2 | MT1G | Metallothionein-1G (PTHR23299:SF3) | | | | | |
|
| P35749 | MYH11_
HUMAN | Myosin-11 | MYH11 | Myosin-11
(PTHR13140:SF335) | G-protein modulator
(PC00095);
actin-binding
motor protein (PC00022); cell
junction protein
(PC00085) | Motor activity
(GO:0003824); structural
constituent of cytoskeleton (GO:0016787); protein
binding (GO:0016462);
enzyme regulator
activity (GO:0003774) | Metabolic process
(GO:0008152);
cytokinesis (GO:0009987);
cellular component
movement (GO:0000910);
mitosis (GO:0006928);
cell communication
(GO:0007049); muscle
contraction (GO:0007067);
sensory perception
of sound (GO:0007154);
sensory perception (GO:0032501);
mesoderm development
(GO:0044707); anatomical
structure morphogenesis
(GO:0003008); muscle organ
development (GO:0006936);
intracellular protein
transport (GO:0007605);
vesicle-mediated transport (GO:0050877); regulation
of catalytic activity
(GO:0007600); cellular
component organization
(GO:0032502) | Plasma membrane
(GO:0016020); actin
cytoskeleton
(GO:0005886); intracellular
(GO:0043226) | Inflammation mediated
by chemokine and
cytokine signaling
pathway→myosin;
nicotinic acetylcholine
receptor signaling
pathway→myosin;
cytoskeletal regulation
by Rho
GTPase→myosin
light chain |
|
| P20929 | NEBU_
HUMAN | Nebulin | NEB | Nebulin (PTHR11039:SF37) | | | | | |
|
| Q13442 | HAP28_
HUMAN | 28 kDa heat-
and acid-stable
phosphoprotein | PDAP1 | 28 kDa heat- and
acid-stable
phosphoprotein
(PTHR22055:SF0) | | | | | |
|
| P13667 | PDIA4_
HUMAN | Protein disulfide-
isomerase A4 | PDIA4 | Protein
disulfide-isomerase A4 (PTHR18929:SF110) | | Isomerase activity
(GO:0003824) | Protein folding (GO:0008152);
cellular process (GO:0044238);
response to stress
(GO:0019538) | Organelle (GO:0043226);
cytoplasm (GO:0044464) | |
|
| Q9UHV9 | PFD2_
HUMAN | Prefoldin subunit 2 | PFDN2 | PREFOLDIN
SUBUNIT 2
(PTHR13303:SF0) | Chaperone (PC00072) | | protein folding
(GO:0008152) | | |
|
| O15212 | PFD6_
HUMAN | Prefoldin subunit 6 | PFDN6 | Prefoldin subunit 6 (PTHR21431:SF0) | | Protein binding
(GO:0005488) | Protein complex
assembly (GO:0008152);
cellular process
(GO:0044238); cellular
component organization
(GO:0019538); protein
complex biogenesis
(GO:0006461) | Protein complex
(GO:0032991); cytosol
(GO:0043234) | |
|
| Q01813 | PFKAP_
HUMAN | ATP-dependent
6-phosphofructoki
nase, platelet type | PFKP | 6-Phosphofructokinase
type C
(PTHR13697:SF5) | Carbohydrate kinase
(PC00220); carbohydrate
kinase (PC00137) | Carbohydrate kinase
activity (GO:0003824) | Glycolysis (GO:0008152);
glycolysis (GO:0006091) | | |
|
| P13797 | PLST_
HUMAN | Plastin-3 | PLS3 | Plastin-3 (PTHR19961:SF32) | Nonmotor actin-binding protein (PC00085) | Structural constituent of
cytoskeleton (GO:0005198);
actin binding (GO:0005200) | Cellular process
(GO:0009987); cellular
component morphogenesis
(GO:0032502); cellular
component organization
(GO:0009653) | Actin cytoskeleton
(GO:0043226); intracellular
(GO:0005856) | |
|
| O75334 | LIPA2_
HUMAN | Liprin-alpha-2 | PPFIA2 | Liprin-alpha-2 (PTHR12587:SF6) | | | Cellular process
(GO:0009987);
cell adhesion (GO:0022610);
ectoderm development
(GO:0007155); nervous
system development
(GO:0032502) | | |
|
| P30048 | PRDX3_
HUMAN | Thioredoxin-
dependent
peroxide
reductase, mitochondrial | PRDX3 | Thioredoxin-dependent
peroxide reductase,
mitochondrial
(PTHR10681:SF22) | Peroxidase (PC00176) | Oxidoreductase activity
(GO:0003824); peroxidase
activity (GO:0016491) | Metabolic process
(GO:0008152) | | |
|
| P49721 | PSB2_
HUMAN | Proteasome
subunit beta
type-2 | PSMB2 | Proteasome subunit
beta type-2 (PTHR11599:SF6) | | | | | |
| Q13200 | PSMD2_
HUMAN | 26S proteasome
non-ATPase
regulatory
subunit 2 | PSMD2 | 26S proteasome
non-ATPase regulatory
subunit 2 (PTHR10943:SF1) | Enzyme modulator (PC00095) | Catalytic activity
(GO:0003824); protein
binding (GO:0005488); enzyme regulator
activity (GO:0005515) | Proteolysis (GO:0008152);
cell cycle (GO:0044238);
regulation of catalytic
activity (GO:0019538) | | Ubiquitin proteasome
pathway→26S
proteasome; |
|
| O00233 | PSMD9_
HUMAN | 26S proteasome
non-ATPase
regulatory
subunit 9 | PSMD9 | 26S proteasome
non-ATPase regulatory
subunit 9 (PTHR12651:SF1) | Enzyme modulator (PC00095) | | Protein complex
assembly (GO:0008152);
cellular component
organization (GO:0044238);
protein complex
biogenesis (GO:0019538) | Protein complex
(GO:0032991); organelle
(GO:0043234); intracellular
(GO:0043226) | Ubiquitin proteasome
pathway→26S
proteasome; |
|
| P06454 | PTMA_
HUMAN | Prothymosin
alpha [cleaved
into:
prothymosin
alpha,
N-terminally
processed;
thymosin
alpha-1] | PTMA | Prothymosin alpha (PTHR22745:SF0) | | | Nucleobase-containing
compound metabolic
process (GO:0008152) | | |
|
| P20962 | PTMS_
HUMAN | Parathymosin | PTMS | Parathymosin
(PTHR22745:SF3) | | | Nucleobase-containing
compound metabolic
process (GO:0008152) | | |
|
| P26373 | RL13_
HUMAN | 60S ribosomal
protein L13 | RPL13 | 60S ribosomal protein
L13 (PTHR11722:SF0) | Ribosomal protein (PC00171) | Structural constituent
of ribosome (GO:0005198);
nucleic acid binding
(GO:0003735) | Translation (GO:0008152) | | |
|
| P62277 | RS13_
HUMAN | 40S ribosomal
protein S13 | RPS13 | 40S ribosomal protein S13
(PTHR11885:SF6) | Ribosomal protein (PC00171) | Structural constituent of ribosome (GO:0005198);
nucleic acid binding
(GO:0003735) | Protein metabolic
process (GO:0008152) | | |
|
| P62857 | RS28_
HUMAN | 40S ribosomal
protein S28 | RPS28 | 40S ribosomal
protein S28 (PTHR10769:SF4) | Ribosomal protein (PC00171) | Structural molecule
activity (GO:0005198) | Cellular process
(GO:0009987);
RNA localization
(GO:0051179);
nucleobase-containing
compound transport
(GO:0006403); nuclear
transport (GO:0006810);
cellular component
biogenesis (GO:0015931) | Ribosome (GO:0032991);
organelle (GO:0030529);
cytosol (GO:0005840) | |
|
| Q8NC51 | PAIRB_
HUMAN | Plasminogen
activator inhibitor
1 RNA-binding
protein | SERBP1 | Plasminogen
activator inhibitor 1
RNA-binding protein (PTHR12299:SF29) | RNA-binding protein (PC00171) | RNA binding
(GO:0005488) | Primary metabolic
process (GO:0008152) | | |
|
| Q9H299 | SH3L3_
HUMAN | SH3 domain-
binding glutamic
acid-rich-like
protein 3 | SH3BGRL3 | SH3 domain-binding
glutamic acid-rich-like
protein 3
(PTHR12232:SF3) | | | | | |
|
| P11166 | GTR1_
HUMAN | Solute carrier
family 2, facilitated
glucose transporter
member 1 | SLC2A1 | Solute carrier family 2,
facilitated glucose
transporter member 1
(PTHR23503:SF51) | | | | | Gonadotropin releasing
hormone receptor
pathway→Glut1;
gonadotropin releasing
hormone receptor
pathway→Glut1;
gonadotropin releasing
hormone receptor
pathway→Glut1 |
|
| P22528 | SPR1B_
HUMAN | Cornifin-B | SPRR1B | Cornifin-B
(PTHR23263:SF47) | | | | | |
|
| Q9Y6N5 | SQRD_
HUMAN | Sulfide:quinone
oxidoreductase,
mitochondrial | SQRDL | Sulfide:quinone
oxidoreductase,
mitochondrial
(PTHR10632:SF2) | | | | | |
|
| Q16629 | SRSF7_
HUMAN | Serine/arginine-
rich splicing
factor 7 | SRSF7 | | | | | | |
|
| P16949 | STMN1_
HUMAN | Stathmin | STMN1 | Stathmin
(PTHR10104:SF5) | | Cytoskeletal protein
binding (GO:0005488) | Cellular process
(GO:0009987);
single-multicellular
organism process
(GO:0032501); cell
differentiation (GO:0044707);
nervous system
development (GO:0032502);
regulation of biological
process (GO:0030154);
cytoskeleton organization
(GO:0048731) | Intracellular (GO:0044464);
cell projection (GO:0005622) | Cytoskeletal regulation
by Rho
GTPase→stathmin |
|
| P61956 | SUMO2_
HUMAN | Small
ubiquitin-related
modifier 2 | SUMO2 | Small ubiquitin-related
modifier 2-related
(PTHR10562:SF11) | | | Cellular protein
modification process
(GO:0008152); cell cycle
(GO:0044238) | | |
|
| P63313 | TYB10_
HUMAN | Thymosin beta-10 | TMSB10 | Thymosin beta-10
(PTHR12021:SF10) | | | | | |
|
| P62328 | TYB4_
HUMAN | Thymosin beta-4 | TMSB4X | Thymosin beta-4
(PTHR12021:SF13) | | | | | |
|
| P67936 | TPM4_
HUMAN | Tropomyosin
alpha-4 chain | TPM4 | Tropomyosin
alpha-4 chain
(PTHR19269:SF40) | Actin-binding motor protein (PC00085) | Motor activity
(GO:0003824);
structural constituent
of cytoskeleton
(GO:0016787) | Metabolic process
(GO:0008152); cellular
component movement
(GO:0009987); muscle
contraction (GO:0006928);
ectoderm development
(GO:0032501); mesoderm
development (GO:0044707);
cellular component
morphogenesis (GO:0003008);
nervous system development
(GO:0006936); muscle organ
development (GO:0032502);
cellular component
organization (GO:0007398) | Actin cytoskeleton
(GO:0043226); intracellular
(GO:0005856) | |
| Q9C030 | TRIM6_
HUMAN | Tripartite
motif-containing
protein 6 | TRIM6 | Tripartite
motif-containing
protein 6
(PTHR24103:SF348) | | | | | |
|
| Q13509 | TBB3_
HUMAN | Tubulin beta-3
chain | TUBB3 | Tubulin beta-3 chain (PTHR11588:SF43) | Tubulin (PC00085) | Structural constituent
of cytoskeleton
(GO:0005198) | Cell cycle (GO:0009987);
anatomical structure
morphogenesis (GO:0007049);
intracellular protein
transport (GO:0032502) | Protein complex
(GO:0032991); intracellular
(GO:0043234) | Huntington
disease→beta-tubulin; Huntington
disease→microtubule;
cytoskeletal regulation
by Rho GTPase→tubulin |
|
| O75152 | ZC11A_
HUMAN | Zinc finger
CCCH domain-
containing
protein 11A | ZC3H11A | Zinc finger CCCH
domain-containing
protein 11A
(PTHR15725:SF2) | Nucleic acid binding (PC00171) | Nucleic
acid binding
(GO:0005488) | | | |
|
